South Korea's Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy's approval in M...
SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- CorestemChemon (KOSDAQ: 166480)is entering a crit...
Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precisi...
Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for hi...
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potent...
